Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Total Antioxidant Capacity and Frailty in Older Men.
Tembo MC, Holloway-Kew KL, Bortolasci CC, Sui SX, Brennan-Olsen SL, Williams LJ, Kotowicz MA, Pasco JA. Tembo MC, et al. Among authors: bortolasci cc. Am J Mens Health. 2020 Sep-Oct;14(5):1557988320946592. doi: 10.1177/1557988320946592. Am J Mens Health. 2020. PMID: 32938316 Free PMC article.
Metformin is Protective Against the Development of Mood Disorders.
Lake J, Bortolasci CC, Stuart AL, Pasco JA, Kidnapillai S, Spolding B, Truong TTT, Panizzutti B, Liu ZSJ, Dean OM, Crowley T, Richardson M, Kim JH, Berk M, Williams LJ, Walder K. Lake J, et al. Among authors: bortolasci cc. Pharmacopsychiatry. 2023 Jan;56(1):25-31. doi: 10.1055/a-1936-3580. Epub 2022 Sep 28. Pharmacopsychiatry. 2023. PMID: 36170869 Free article.
The role of metformin as a treatment for neuropsychiatric illness.
Dodd S, Sominsky L, Siskind D, Bortolasci CC, Carvalho AF, Maes M, Walker AJ, Walder K, Yung AR, Williams LJ, Myles H, Watson T, Berk M. Dodd S, et al. Among authors: bortolasci cc. Eur Neuropsychopharmacol. 2022 Nov;64:32-43. doi: 10.1016/j.euroneuro.2022.09.002. Epub 2022 Sep 30. Eur Neuropsychopharmacol. 2022. PMID: 36191545 Review.
Interleukin-6 and total antioxidant capacity levels following N-acetylcysteine and a combination nutraceutical intervention in a randomised controlled trial for bipolar disorder.
Bortolasci CC, Voigt C, Turner A, Mohebbi M, Gray L, Dodd S, Walder K, Berk M, Cotton SM, Malhi GS, Ng CH, Dowling N, Sarris J, Dean OM. Bortolasci CC, et al. Acta Neuropsychiatr. 2020 Dec;32(6):313-320. doi: 10.1017/neu.2020.25. Epub 2020 Jun 30. Acta Neuropsychiatr. 2020. PMID: 32600481 Clinical Trial.
Systemic inflammation and grey matter volume in schizophrenia and bipolar disorder: Moderation by childhood trauma severity.
Quidé Y, Bortolasci CC, Spolding B, Kidnapillai S, Watkeys OJ, Cohen-Woods S, Carr VJ, Berk M, Walder K, Green MJ. Quidé Y, et al. Among authors: bortolasci cc. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 8;105:110013. doi: 10.1016/j.pnpbp.2020.110013. Epub 2020 Jun 12. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 32540496
Exploring interleukin-6, lipopolysaccharide-binding protein and brain-derived neurotrophic factor following 12 weeks of adjunctive minocycline treatment for depression.
Hasebe K, Mohebbi M, Gray L, Walker AJ, Bortolasci CC, Turner A, Berk M, Walder K, Maes M, Kanchanatawan B, Ashton MM, Berk L, Ng CH, Malhi GS, Singh AB, Dean OM. Hasebe K, et al. Among authors: bortolasci cc. Acta Neuropsychiatr. 2022 Aug;34(4):220-227. doi: 10.1017/neu.2021.44. Epub 2021 Dec 23. Acta Neuropsychiatr. 2022. PMID: 34937590 Clinical Trial.
63 results